TPI to Host Third Quarter Fiscal Year 2014 Earnings Conference Call on Thursday, May 15, 2014 at 9:00 a.m. ET - AZTV7/Cable 13, Me-TV 7.2, HSN 7.3, Phoenix-Prescott, AZ

TPI to Host Third Quarter Fiscal Year 2014 Earnings Conference Call on Thursday, May 15, 2014 at 9:00 a.m. ET

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Tianyin Pharmaceutical Co., Inc.

CHENGDU, China, May 8, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), today announced that the earnings conference call for the third quarter of fiscal year 2014 ended March 31, 2014 will be held at 9:00 a.m. ET on Thursday, May 15th, 2014.

Interested parties may access the call by dialing:

TOLL-FREE    1-877-941-4775
TOLL/INTERNATIONAL    1-480-629-9761
Conference ID:  4682932

It is advisable to dial in approximately 5 minutes prior to the start of the call.

Replay Dial-In Numbers:
TOLL-FREE   1-877-870-5176
TOLL/INTERNATIONAL   1-858-384-5517
From:  05/15/14 @ 12:00 pm Eastern Time
To:      05/29/14 @ 11:59 pm Eastern Time
Replay Pin Number:  4682932

This call is being web cast by ViaVid Broadcasting and can be accessed at ViaVid's website at the following link: http://public.viavid.com/confirmation/confirmwebcast.php?id=o5aroKCc

About TPI

Headquartered at Chengdu, China, TPI is a pharmaceutical company that specializes in the development, manufacturing, marketing and sales of patented biopharmaceutical, mTCM, branded generics and API. TPI currently manufactures a comprehensive portfolio of 58 products, 24 of which are listed in the highly selective national medicine reimbursement list, 10 are included in the essential drug list (EDL) of China. For more information about TPI, please visit: http://www.tianyinpharma.com

Safe Harbor Statement

The Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.

For more information, please visit: http://www.tianyinpharma.com, or email: ir@tpi.asia     
Tel: +86-28-8551-6696 (Chengdu, China)
Address: Tianyin Pharmaceutical
23rd Floor, Unionsun Yangkuo Plaza     
No. 2, Block 3, South Renmin Road
Chengdu, 610041
China

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and AZ-TV. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.